IRD

Opus Genetics, Inc.

IRD · CIK 1228627 · Annual (10-K) · Last 8 years

Financial Trends

Revenue$11M
20172024
Net Income−$58M
20172024
Operating CF−$26M
20172024
Free Cash Flow
20172024

Income Statement

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕FY 2017↕
Revenue$0.0B$0.0B$0.0B$0.0B————
Cost of Revenue——————$0.0B—
Gross Profit————————
R&D Expense—————$0.0B$0.0B$0.0B
SG&A Expense————————
Operating Income$-0.1B$-0.0B$0.0B$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B
Net Income$-0.1B$-0.0B$0.0B$-0.1B$-0.0B$-0.0B$-0.0B$-0.0B
EPS (Basic)$-2.15$-0.46$0.90$-3.82——$-0.12$-0.12
EPS (Diluted)$-2.15$-0.46$0.87$-3.82——$-0.12$-0.12

Balance Sheet

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕FY 2017↕
Total Assets$0.0B$0.1B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Current Assets$0.0B$0.1B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Cash & Equivalents$0.0B$0.1B$0.0B———$0.0B$0.0B
Total Liabilities$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Current Liabilities$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B——
Stockholders' Equity$0.0B$0.0B$0.0B$0.0B$-0.0B$0.0B$0.0B$0.0B

Cash Flow Statement

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕FY 2017↕
Operating Cash Flow$-0.0B$-0.0B$0.0B$-0.0B$-0.0B$-0.0B$-0.0B—
Investing Cash Flow$0.0B$0.0B$0.0B$-0.0B$0.0B$0.0B$0.0B—
Capital Expenditures————$0.0B———
Financing Cash Flow$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B—
← Companies